67 results
Page 2 of 4
8-K
EX-99.1
sa2j4zhjrgty4
16 Jun 22
Other Events
7:00am
8-K
EX-99.1
umf13ntxkmdite2pt2l
9 May 22
Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones
4:31pm
8-K
EX-99.1
0w5pn6m7v2lgpsews0zd
28 Feb 22
Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones
4:36pm
8-K
EX-99.1
tvtqjk0o b3nae
10 Jan 22
Regulation FD Disclosure
7:01am
8-K
fg8tgb86or3ibsz80
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.2
oxeze
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.1
6r064o3fa4j t17iytrd
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.2
6rbg68
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
8-K
EX-99.1
mu0jb
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
8-K
7ox1q
30 Sep 21
Other Events
7:00am
8-K
EX-99.1
j97i hyuq3iffd6oear
9 Aug 21
Business Highlights and Anticipated Second Half 2021 Milestones
7:01am
8-K
EX-99.2
pezm0izyqzy
19 May 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
x597n 0di4
19 May 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
7f2hg4vx 3n2vb9y536y
7 May 21
Business Highlights and 2021 Anticipated Milestones
7:00am